- Current status
- AHSCT is a standard of care of RRMS
- Wykłady na kursie specjalizacyjnym – transplantologia
- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
Monthly Archives: September 2016
I was very happy to be invited to Bioinnovation Summit in Gdańs (http://www.bioinnovation.pl/) where I talked about the stem cells. The presentation can be downloaded here.
The new trial in Spain – probably one of the many. Basing on the success of the “Berlin patient” – a man infected with HIV who got bone marrow transplantation without CCR5 receptor and got cured of HIV – there … Continue reading
I have just prepared short presentation on news in cord blood transplantation. There are some developments I find very exciting. The presentation can be downloaded here:2016 Namnażanie krwi pępowinowej